{
  "$schema": "folio-library-document/v1",
  "id": "10665-372197",
  "title": "Pandemic influenza preparedness framework: annual progress report, 1 January – 31 December 2022",
  "variant": "pdf",
  "pages": 40,
  "tocSource": "outline",
  "tocMethod": null,
  "toc": [
    {
      "level": 1,
      "title": "Acronyms & abbreviations",
      "number": null,
      "page": 6,
      "pageLabel": "iv",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-000-acronyms-abbreviations"
    },
    {
      "level": 1,
      "title": "Introduction",
      "number": null,
      "page": 7,
      "pageLabel": "1",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-001-introduction"
    },
    {
      "level": 1,
      "title": "PIP Framework implementation overview",
      "number": null,
      "page": 9,
      "pageLabel": "3",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-002-pip-framework-implementation-overview"
    },
    {
      "level": 1,
      "title": "Technical and financial implementation progress",
      "number": null,
      "page": 12,
      "pageLabel": "6",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-003-technical-and-financial-implementation-progress"
    },
    {
      "level": 2,
      "title": "Laboratory & surveillance",
      "number": null,
      "page": 14,
      "pageLabel": "8",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-004-laboratory-surveillance"
    },
    {
      "level": 2,
      "title": "Burden of disease",
      "number": null,
      "page": 16,
      "pageLabel": "10",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-005-burden-of-disease"
    },
    {
      "level": 2,
      "title": "Regulatory capacity building",
      "number": null,
      "page": 17,
      "pageLabel": "11",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-006-regulatory-capacity-building"
    },
    {
      "level": 2,
      "title": "Risk communications & community engagement",
      "number": null,
      "page": 18,
      "pageLabel": "12",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-007-risk-communications-community-engagement"
    },
    {
      "level": 2,
      "title": "Planning for deployment",
      "number": null,
      "page": 19,
      "pageLabel": "13",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-008-planning-for-deployment"
    },
    {
      "level": 2,
      "title": "Influenza pandemic preparedness planning",
      "number": null,
      "page": 20,
      "pageLabel": "14",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-009-influenza-pandemic-preparedness-planning"
    },
    {
      "level": 2,
      "title": "PIP Framework Secretariat",
      "number": null,
      "page": 21,
      "pageLabel": "15",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-010-pip-framework-secretariat"
    },
    {
      "level": 1,
      "title": "Stories from the field",
      "number": null,
      "page": 23,
      "pageLabel": "17",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-011-stories-from-the-field"
    },
    {
      "level": 1,
      "title": "Annex: Financial report",
      "number": null,
      "page": 31,
      "pageLabel": "25",
      "confidence": null,
      "evidence": null,
      "source": "outline",
      "section": "sec-012-annex-financial-report"
    }
  ],
  "sections": [
    {
      "id": "sec-front-matter",
      "number": null,
      "title": "Front matter",
      "level": 1,
      "pageStart": 1,
      "pageEnd": 6,
      "labelStart": "a",
      "labelEnd": "iv",
      "words": 786,
      "summary": {
        "text": "The front matter of the Pandemic Influenza Preparedness (PIP) Framework annual progress report for 2022, with the cover, ISBN and copyright page under a CC BY-NC-SA 3.0 IGO licence. It also contains the contents and a list of acronyms used in the report.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "influenza pandemic",
          "heading": false
        },
        {
          "term": "influenza preparedness",
          "heading": false
        },
        {
          "term": "influenza virus",
          "heading": false
        },
        {
          "term": "preparedness framework",
          "heading": false
        },
        {
          "term": "january december",
          "heading": false
        },
        {
          "term": "preparedness planning",
          "heading": false
        },
        {
          "term": "report january",
          "heading": false
        },
        {
          "term": "report month",
          "heading": false
        }
      ],
      "extract": "2022 6-MONTH REPORT 12-MONTH REPORT 18-MONTH REPORT 24-MONTH REPORT 2023 Pandemic Inﬂuenza Preparedness Framework Annual progress report 1 January – 31 December 2022 Pandemic Influenza Preparedness Framework Annual Progress Report 1 January – 31 December 2022 Pandemic Influenza Preparedness Framework: annual progress report, 1 January – 31 December 2022 ISBN 978-92-4-007690-7 (electronic version) ISBN",
      "extractCut": true,
      "blocks": [
        "library/10665-372197/blocks/prose-sec-front-matter"
      ]
    },
    {
      "id": "sec-000-acronyms-abbreviations",
      "number": null,
      "title": "Acronyms & abbreviations",
      "level": 1,
      "pageStart": 6,
      "pageEnd": 7,
      "labelStart": "iv",
      "labelEnd": "1",
      "words": 3,
      "summary": {
        "text": "A heading page for the list of acronyms and abbreviations.",
        "status": "draft"
      },
      "keywords": [],
      "extract": "Acronyms & abbreviations",
      "extractCut": false
    },
    {
      "id": "sec-001-introduction",
      "number": null,
      "title": "Introduction",
      "level": 1,
      "pageStart": 7,
      "pageEnd": 9,
      "labelStart": "1",
      "labelEnd": "3",
      "words": 441,
      "summary": {
        "text": "Introduces the Pandemic Influenza Preparedness Framework, which aims to improve sharing of influenza viruses with pandemic potential through WHO's GISRS network and to widen developing countries' access to vaccines and other supplies. It explains the Partnership Contribution, an annual payment by manufacturers that use GISRS, and how it funds preparedness capacity building, pandemic response and the PIP Secretariat, and thanks the staff who carry out the work.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pandemic preparedness",
          "heading": false
        },
        {
          "term": "pip secretariat",
          "heading": false
        },
        {
          "term": "pip framework",
          "heading": false
        },
        {
          "term": "hlip",
          "heading": false
        },
        {
          "term": "preparedness capacity",
          "heading": false
        },
        {
          "term": "financial implementation",
          "heading": false
        },
        {
          "term": "influenza",
          "heading": false
        },
        {
          "term": "gisrs",
          "heading": false
        }
      ],
      "extract": "Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The key goals include: to improve and strengthen the sharing of influenza viruses with human pandemic potential through the WHO Global Influenza Surveillance and Response System (GISRS), and to increase the access of developing countries to vaccines and other pandemic response supplies.",
      "extractCut": true
    },
    {
      "id": "sec-002-pip-framework-implementation-overview",
      "number": null,
      "title": "PIP Framework implementation overview",
      "level": 1,
      "pageStart": 9,
      "pageEnd": 12,
      "labelStart": "3",
      "labelEnd": "6",
      "words": 690,
      "summary": {
        "text": "Gives an overview of PIP Framework implementation to the end of 2022, with infographics on Partnership Contribution collection, totalling about US$ 282.9 million from industry, and yearly collection rates against a US$ 28 million target. It also reports the 2022–2023 budgets, funding and spending for preparedness, response and the secretariat, and progress on agreements with manufacturers to secure pandemic products.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pip framework",
          "heading": true
        },
        {
          "term": "pip secretariat",
          "heading": false
        },
        {
          "term": "recipient member",
          "heading": false
        },
        {
          "term": "biennial budget",
          "heading": false
        },
        {
          "term": "member states",
          "heading": false
        },
        {
          "term": "broader pandemic",
          "heading": false
        },
        {
          "term": "future pandemic",
          "heading": false
        },
        {
          "term": "smta",
          "heading": false
        }
      ],
      "extract": "implementation overview PIP PC collection (As of 31 December 2022) PERCENTAGE OF TOTAL PC RECEIVED FROM CONTRIBUTORS $282.9M CONTRIBUTED BY INDUSTRY b MILLION US$ 2012 a 30 25 20 15 10 5 0 TARGET 28M /YEAR 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 99% 97% 98% 97% 97% 97% 97% 98% 97% 68% a In 2012, contributions were made voluntarily. b Figure includes PSC. PC collection for previous unpaid contributions and",
      "extractCut": true
    },
    {
      "id": "sec-003-technical-and-financial-implementation-progress",
      "number": null,
      "title": "Technical and financial implementation progress",
      "level": 1,
      "pageStart": 12,
      "pageEnd": 14,
      "labelStart": "6",
      "labelEnd": "8",
      "words": 356,
      "summary": {
        "text": "A reading guide explaining how the following output pages present budgets, funds implemented, highlights, milestones and indicators, shown as a template with placeholder values.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "response trainings",
          "heading": false
        },
        {
          "term": "severity assessments",
          "heading": false
        },
        {
          "term": "biennial budget",
          "heading": false
        },
        {
          "term": "funds implemented",
          "heading": false
        },
        {
          "term": "output reading",
          "heading": false
        },
        {
          "term": "excluding psc",
          "heading": false
        },
        {
          "term": "risk assessments",
          "heading": false
        },
        {
          "term": "influenza",
          "heading": false
        }
      ],
      "extract": "implementation progress OUTPUT READING GUIDE NOTE TO READERS Please read this Output Reading Guide which provides clarity on the data reported in this section. Output name & statement Funds implemented cumulatively at deliverable level (excluding PSC) Indicators: progress updated annually. Results are presented against biennial targets (Baselines are as of 31 December 2017) Proportion of funds implemented from the",
      "extractCut": true
    },
    {
      "id": "sec-004-laboratory-surveillance",
      "number": null,
      "title": "Laboratory & surveillance",
      "level": 2,
      "pageStart": 14,
      "pageEnd": 16,
      "labelStart": "8",
      "labelEnd": "10",
      "words": 1221,
      "summary": {
        "text": "Reports 2022 progress on the laboratory and surveillance output, which supports national influenza systems contributing to GISRS, with its budget and spending by deliverable. Highlights include ten published risk assessments at the human-animal interface, countries reporting severity assessments, training on virus detection and reporting of influenza data to global platforms. Indicators track timely sharing of viruses and specimens with WHO collaborating centres.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "zoonotic influenza",
          "heading": false
        },
        {
          "term": "influenza viruses",
          "heading": false
        },
        {
          "term": "pandemic influenza",
          "heading": false
        },
        {
          "term": "influenza severity",
          "heading": false
        },
        {
          "term": "influenza virus",
          "heading": false
        },
        {
          "term": "influenza sentinel",
          "heading": false
        },
        {
          "term": "shared influenza",
          "heading": false
        },
        {
          "term": "trainings completed",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: National influenza L&S systems contribute to GISRS for timely risk assessment & response measures IMPLEMENTED: $18.2M $6.5M DELIVERABLE A DELIVERABLE B DELIVERABLE C MILESTONES MILESTONES MILESTONES IMPLEMENTED $2M IMPLEMENTED $2.1M IMPLEMENTED $954K HIGHLIGHTS HIGHLIGHTS HIGHLIGHTS Risk and severity of influenza, including at the human-animal interface, are routinely assessed Quality",
      "extractCut": true
    },
    {
      "id": "sec-005-burden-of-disease",
      "number": null,
      "title": "Burden of disease",
      "level": 2,
      "pageStart": 16,
      "pageEnd": 17,
      "labelStart": "10",
      "labelEnd": "11",
      "words": 583,
      "summary": {
        "text": "Reports progress on influenza burden of disease work, noting that 50 countries, most of them lower-middle-income, had published estimates by 2022 and others planned to calculate them. It also tracks the use of estimates in policy and development of a tool to estimate burden across the severity spectrum.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "disease burden",
          "heading": true
        },
        {
          "term": "influenza-associated hospitalization",
          "heading": false
        },
        {
          "term": "bod estimates",
          "heading": false
        },
        {
          "term": "influenza-associated non-respiratory",
          "heading": false
        },
        {
          "term": "pyramid tool",
          "heading": false
        },
        {
          "term": "influenza averted",
          "heading": false
        },
        {
          "term": "seasonal influenza",
          "heading": false
        },
        {
          "term": "influenza vaccination",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: DELIVERABLE A DELIVERABLE B MILESTONE MILESTONE IMPLEMENTED $120K IMPLEMENTED $211K HIGHLIGHTS HIGHLIGHTS Number of countries in each burden of disease estimate development stage (N=194) Representative national, regional and global disease burden estimates are available Disease burden findings are communicated to national and international expert bodies in a format that promotes",
      "extractCut": true
    },
    {
      "id": "sec-006-regulatory-capacity-building",
      "number": null,
      "title": "Regulatory capacity building",
      "level": 2,
      "pageStart": 17,
      "pageEnd": 18,
      "labelStart": "11",
      "labelEnd": "12",
      "words": 457,
      "summary": {
        "text": "Reports progress on regulatory capacity building for pandemic influenza products, including countries that improved emergency regulatory preparedness after WHO benchmarking, self-benchmarking assessments and WHO workshops. It also tracks adoption of fast-track approval pathways and an update of WHO's regulatory preparedness guideline.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "regulatory capacity",
          "heading": true
        },
        {
          "term": "pandemic influenza",
          "heading": false
        },
        {
          "term": "regulatory preparedness",
          "heading": false
        },
        {
          "term": "pandemic products",
          "heading": false
        },
        {
          "term": "emergency regulatory",
          "heading": false
        },
        {
          "term": "regulatory capacities",
          "heading": false
        },
        {
          "term": "regulatory pathways",
          "heading": false
        },
        {
          "term": "benchmarking assessments",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: DELIVERABLE A DELIVERABLE B MILESTONES MILESTONES IMPLEMENTED $599K IMPLEMENTED $623K HIGHLIGHTS HIGHLIGHTS Refinements made to WHO GBT Countries WHO-benchmarked Countries self-benchmarked IDP follow-up visits National regulatory capacity for pandemic influenza products is strengthened Adoption of regulatory pathways that accelerate approval for use of pandemic influenza products is promoted",
      "extractCut": true
    },
    {
      "id": "sec-007-risk-communications-community-engagement",
      "number": null,
      "title": "Risk communications & community engagement",
      "level": 2,
      "pageStart": 18,
      "pageEnd": 19,
      "labelStart": "12",
      "labelEnd": "13",
      "words": 573,
      "summary": {
        "text": "Reports progress on influenza risk communication and community engagement, including work with WHO's EPI-WIN network on webinars with faith, youth and workplace communities and technical support to countries. Indicators cover a community platform and countries adapting a social listening approach for acute respiratory infections.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pandemic influenza",
          "heading": false
        },
        {
          "term": "influenza preparedness",
          "heading": false
        },
        {
          "term": "community engagement",
          "heading": true
        },
        {
          "term": "epi-win communities",
          "heading": false
        },
        {
          "term": "influenza modules",
          "heading": false
        },
        {
          "term": "influenza risk",
          "heading": false
        },
        {
          "term": "respiratory pathogen",
          "heading": false
        },
        {
          "term": "ears",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: Tools and guidance are available for countries to enhance influenza risk communication and community engagement IMPLEMENTED: $2.2M $597K DELIVERABLE A Countries and frontline responders have access to resources for influenza risk communication, community engagement and social science-based interventions Technical assistance is provided to countries to plan and exercise influenza risk",
      "extractCut": true
    },
    {
      "id": "sec-008-planning-for-deployment",
      "number": null,
      "title": "Planning for deployment",
      "level": 2,
      "pageStart": 19,
      "pageEnd": 20,
      "labelStart": "13",
      "labelEnd": "14",
      "words": 508,
      "summary": {
        "text": "Reports progress on planning the deployment of pandemic supplies, including a foresight project to estimate needs for vaccines, antivirals, diagnostics and therapeutics. It also covers national deployment planning and support for sustainable influenza vaccine procurement and production.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pandemic influenza",
          "heading": false
        },
        {
          "term": "influenza preparedness",
          "heading": false
        },
        {
          "term": "deployment",
          "heading": true
        },
        {
          "term": "seasonal influenza",
          "heading": false
        },
        {
          "term": "influenza vaccination",
          "heading": false
        },
        {
          "term": "influenza vaccine",
          "heading": false
        },
        {
          "term": "national deployment",
          "heading": false
        },
        {
          "term": "global deployment",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: Plans for effective & efficient deployment of pandemic supplies are optimized IMPLEMENTED: $1.6M $375K DELIVERABLE A DELIVERABLE B DELIVERABLE C IMPLEMENTED $170K IMPLEMENTED $0K IMPLEMENTED $205K A common approach to manage global deployment operations is developed and regularly tested with stakeholders and deployment partners National deployment planning process is revised and updated",
      "extractCut": true
    },
    {
      "id": "sec-009-influenza-pandemic-preparedness-planning",
      "number": null,
      "title": "Influenza pandemic preparedness planning",
      "level": 2,
      "pageStart": 20,
      "pageEnd": 21,
      "labelStart": "14",
      "labelEnd": "15",
      "words": 372,
      "summary": {
        "text": "Reports progress on national pandemic influenza preparedness plans, noting that 37 of 65 funded countries have plans based on WHO guidance and that several held planning workshops or exercised their plans in 2022.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pandemic preparedness",
          "heading": true
        },
        {
          "term": "pandemic influenza",
          "heading": true
        },
        {
          "term": "ippp",
          "heading": false
        },
        {
          "term": "multi sectoral",
          "heading": false
        },
        {
          "term": "simulation exercise",
          "heading": false
        },
        {
          "term": "recipient",
          "heading": false
        },
        {
          "term": "exercise package",
          "heading": false
        },
        {
          "term": "exercised",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: National pandemic influenza preparedness & response plans are updated in the context of all-hazards preparedness and global health security IMPLEMENTED: $2M $430K MILESTONE HIGHLIGHTS • Of the 65 IPPP PC recipient countries in the 2022-23 biennium, 37 (59%) now have a plan based on WHO Guidance, of which five updated their plan in 2022. • Countries are developing their pandemic plans in a",
      "extractCut": true
    },
    {
      "id": "sec-010-pip-framework-secretariat",
      "number": null,
      "title": "PIP Framework Secretariat",
      "level": 2,
      "pageStart": 21,
      "pageEnd": 23,
      "labelStart": "15",
      "labelEnd": "17",
      "words": 633,
      "summary": {
        "text": "Reports on the work of the PIP Framework Secretariat in managing the Framework, including governance meetings and reports, collection and reporting of the Partnership Contribution, and negotiation of Standard Material Transfer Agreements 2 with manufacturers. Indicators show the share of contributions received in the year invoiced and the share of manufacturers with concluded agreements.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "pip secretariat",
          "heading": true
        },
        {
          "term": "pip framework",
          "heading": true
        },
        {
          "term": "pip advisory",
          "heading": false
        },
        {
          "term": "hlip iii",
          "heading": false
        },
        {
          "term": "advisory group",
          "heading": false
        },
        {
          "term": "agwg",
          "heading": false
        },
        {
          "term": "proportional division",
          "heading": false
        },
        {
          "term": "draft decision",
          "heading": false
        }
      ],
      "extract": "BIENNIAL BUDGET: OUTPUT: The PIP Secretariat leads, manages and supports implementation of the PIP Framework IMPLEMENTED: $5.9M $1.7M DELIVERABLE A DELIVERABLE B DELIVERABLE C IMPLEMENTED $834K IMPLEMENTED $245K IMPLEMENTED $600K Promote the effective implementation of the PIP Framework in a changing environment Collect, implement, monitor, and report on the Partnership Contribution Negotiate and plan to",
      "extractCut": true
    },
    {
      "id": "sec-011-stories-from-the-field",
      "number": null,
      "title": "Stories from the field",
      "level": 1,
      "pageStart": 23,
      "pageEnd": 31,
      "labelStart": "17",
      "labelEnd": "25",
      "words": 2533,
      "summary": {
        "text": "Presents stories from the field, beginning with the 70th anniversary of the Global Influenza Surveillance and Response System, which grew from a 1952 network into one spanning 127 countries, areas and territories. It describes the scale of testing by national influenza centres during the COVID-19 years and GISRS's role in providing viruses for vaccines. Country examples include Nepal's influenza centre taking on SARS-CoV-2 testing and the expansion of integrated surveillance under GISRS Plus. Other stories cover planning to monitor a future pandemic response and integrated respiratory surveillance in Timor-Leste.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "influenza viruses",
          "heading": false
        },
        {
          "term": "seasonal influenza",
          "heading": false
        },
        {
          "term": "influenza pandemic",
          "heading": false
        },
        {
          "term": "influenza surveillance",
          "heading": false
        },
        {
          "term": "influenza sentinel",
          "heading": false
        },
        {
          "term": "influenza burden",
          "heading": false
        },
        {
          "term": "gisrs network",
          "heading": false
        },
        {
          "term": "future influenza",
          "heading": false
        }
      ],
      "extract": "the field The Global Influenza Surveillance & Response System at 70: a public health resource for the world Going from strength to strength in the fight against influenza and other respiratory diseases. \"Influenza is not a national issue; it’s not a national phenomenon – it’s a global phenomenon and you can’t work on it isolated in the country.\" - Dr Olav Hungnes, Director of National Influenza Centre, Norwegian",
      "extractCut": true
    },
    {
      "id": "sec-012-annex-financial-report",
      "number": null,
      "title": "Annex: Financial report",
      "level": 1,
      "pageStart": 31,
      "pageEnd": 40,
      "labelStart": "25",
      "labelEnd": "34",
      "words": 1373,
      "summary": {
        "text": "The financial annex lists the Partnership Contribution received from each manufacturer between 2012 and 2022, led by Sanofi Pasteur, GSK and Roche, totalling about US$ 283 million. Further tables give 2022–2023 budgets, distributions, expenditure and balances for each output and deliverable, and for the secretariat and response funds. It ends with contact details for the PIP Framework Secretariat.",
        "status": "draft"
      },
      "keywords": [
        {
          "term": "vaccines ltd",
          "heading": false
        },
        {
          "term": "biotech ltd",
          "heading": false
        },
        {
          "term": "india ltd",
          "heading": false
        },
        {
          "term": "influenza preparedness",
          "heading": false
        },
        {
          "term": "pandemic influenza",
          "heading": false
        },
        {
          "term": "response funds",
          "heading": false
        },
        {
          "term": "cross corporation",
          "heading": false
        },
        {
          "term": "funds distributed",
          "heading": false
        }
      ],
      "extract": "Financial report Table A.1: PIP Partnership Contribution received from each manufacturer (2012 - 2022) Status as of 31 December 2022 CONTRIBUTORS TOTAL CONTRIBUTIONS (US$) Sanofi Pasteur 65,841,037 Glaxosmithkline (GSK) 63,855,269 Hoffmann - La Roche and Co. Ltd. 59,028,863 Seqirus 22,311,267 Novartis 15,292,743 Medimmune 10,062,070 Kaketsuken (K M Biologics) 5,735,740 Research Foundation for Microbial Disease of",
      "extractCut": true
    }
  ],
  "checks": {
    "tocAlignment": {
      "listed_not_found": {
        "count": 0,
        "items": []
      },
      "found_not_listed": {
        "count": 0,
        "items": []
      },
      "page_mismatch": {
        "count": 0,
        "items": []
      }
    },
    "figureSequenceGaps": [],
    "pageLabelConflicts": {
      "count": 0,
      "items": []
    }
  },
  "withheld": false,
  "keywords": [
    {
      "term": "influenza pandemic",
      "heading": true
    },
    {
      "term": "influenza preparedness",
      "heading": true
    },
    {
      "term": "influenza viruses",
      "heading": false
    },
    {
      "term": "seasonal influenza",
      "heading": false
    },
    {
      "term": "global influenza",
      "heading": false
    },
    {
      "term": "influenza vaccine",
      "heading": false
    },
    {
      "term": "influenza severity",
      "heading": false
    },
    {
      "term": "influenza surveillance",
      "heading": false
    },
    {
      "term": "national influenza",
      "heading": false
    },
    {
      "term": "influenza products",
      "heading": false
    },
    {
      "term": "report influenza",
      "heading": false
    },
    {
      "term": "influenza risk",
      "heading": false
    }
  ],
  "pageLabels": [
    {
      "physical": 1,
      "label": "a",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 2,
      "label": "b",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 3,
      "label": "c",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 4,
      "label": "d",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 5,
      "label": "iii",
      "source": "pdf-labels",
      "confidence": 0.7
    },
    {
      "physical": 6,
      "label": "iv",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 7,
      "label": "1",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 8,
      "label": "2",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 9,
      "label": "3",
      "source": "pdf-labels",
      "confidence": 1
    },
    {
      "physical": 10,
      "label": "4",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 11,
      "label": "5",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 12,
      "label": "6",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 13,
      "label": "7",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 14,
      "label": "8",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 15,
      "label": "9",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 16,
      "label": "10",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 17,
      "label": "11",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 18,
      "label": "12",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 19,
      "label": "13",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 20,
      "label": "14",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 21,
      "label": "15",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 22,
      "label": "16",
      "source": "pdf-labels",
      "confidence": 0.85
    },
    {
      "physical": 23,
      "label": "17",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 24,
      "label": "18",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 25,
      "label": "19",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 26,
      "label": "20",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 27,
      "label": "21",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 28,
      "label": "22",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 29,
      "label": "23",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 30,
      "label": "24",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 31,
      "label": "25",
      "source": "printed",
      "confidence": 1
    },
    {
      "physical": 32,
      "label": "26",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 33,
      "label": "27",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 34,
      "label": "28",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 35,
      "label": "29",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 36,
      "label": "30",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 37,
      "label": "31",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 38,
      "label": "32",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 39,
      "label": "33",
      "source": "printed",
      "confidence": 0.85
    },
    {
      "physical": 40,
      "label": "34",
      "source": "pdf-labels",
      "confidence": 0.7
    }
  ],
  "figures": [],
  "images": [
    {
      "id": "img-p024-1",
      "file": "images/img-p024-1.webp",
      "page": 24,
      "narratives": {
        "en": "A composite photograph for the GISRS 70th anniversary story. On the left, a gloved hand uses a pipette over sample tubes in a modern laboratory; on the right, in a circular black-and-white inset, two men in lab coats work at a bench with a tray of eggs.",
        "ar": "صورة مركّبة لقصة الذكرى السبعين للنظام العالمي لترصد الإنفلونزا والاستجابة لها (GISRS). على اليسار، يد مرتدية قفازًا تستخدم ماصّة فوق أنابيب العينات في مختبر حديث؛ وعلى اليمين، في إطار دائري بالأبيض والأسود، رجلان يرتديان معطفي المختبر يعملان على طاولة عليها صينية بيض.",
        "zh": "用于全球流感监测和应对系统（GISRS）70周年报道的合成照片。左侧，一只戴手套的手在现代实验室中用移液器处理样本管；右侧圆形黑白插图中，两名身穿实验服的男子在工作台前操作一盘鸡蛋。",
        "es": "Una fotografía compuesta para el artículo sobre el 70.º aniversario del GISRS. A la izquierda, una mano enguantada utiliza una pipeta sobre tubos de muestras en un laboratorio moderno; a la derecha, en un recuadro circular en blanco y negro, dos hombres con bata de laboratorio trabajan en una mesa con una bandeja de huevos.",
        "fr": "Une photographie composite pour l’article sur le 70e anniversaire du GISRS. À gauche, une main gantée utilise une pipette au-dessus de tubes d’échantillons dans un laboratoire moderne ; à droite, dans un médaillon circulaire en noir et blanc, deux hommes en blouse de laboratoire travaillent à une paillasse avec un plateau d’œufs.",
        "ru": "Составная фотография к материалу о 70-летии GISRS. Слева рука в перчатке работает пипеткой над пробирками с образцами в современной лаборатории; справа, на круглой черно-белой вставке, двое мужчин в лабораторных халатах работают за столом с лотком яиц."
      },
      "state": "draft"
    },
    {
      "id": "img-p026-1",
      "file": "images/img-p026-1.webp",
      "page": 26,
      "narratives": {
        "en": "A node network diagram visualising emerging trends found in the literature, organised by the PESTLE framework. Six hub nodes labelled Law, Political, Social, Technological, Economic and Environment are linked to many small nodes, each a short headline-style trend (for example on COVAX, vaccine nationalism, mRNA vaccine hubs, artificial intelligence and climate change); most of the small labels are too small to read reliably.",
        "ar": "مخطط شبكي للعُقد يصوّر الاتجاهات الناشئة الواردة في المؤلفات، منظَّمة وفق إطار PESTLE. ترتبط ست عُقد مركزية موسومة بـ: القانون، والسياسة، والمجتمع، والتكنولوجيا، والاقتصاد، والبيئة، بعدد كبير من العُقد الصغيرة، تمثّل كل منها اتجاهًا بعبارة قصيرة على شكل عنوان (مثل كوفاكس، والقومية في مجال اللقاحات، ومراكز لقاحات mRNA، والذكاء الاصطناعي، وتغير المناخ)؛ ومعظم التسميات الصغيرة أصغر من أن تُقرأ بدقة.",
        "zh": "节点网络图，按PESTLE框架展示文献中发现的新兴趋势。六个中心节点分别标为法律、政治、社会、技术、经济和环境，与许多小节点相连，每个小节点为一条简短的标题式趋势（例如关于COVAX、疫苗民族主义、mRNA疫苗中心、人工智能和气候变化）；大多数小标签字太小，无法可靠辨认。",
        "es": "Un diagrama de red de nodos que visualiza las tendencias emergentes encontradas en la literatura, organizadas según el marco PESTLE. Seis nodos centrales etiquetados Law (jurídico), Political (político), Social, Technological (tecnológico), Economic (económico) y Environment (medio ambiente) están conectados a muchos nodos pequeños, cada uno con una tendencia breve en forma de titular (por ejemplo, sobre COVAX, el nacionalismo de las vacunas, los centros de vacunas de ARNm, la inteligencia artificial y el cambio climático); la mayoría de las etiquetas pequeñas son demasiado pequeñas para leerse con fiabilidad.",
        "fr": "Un diagramme en réseau de nœuds représentant les tendances émergentes relevées dans la littérature, organisées selon le cadre PESTLE. Six nœuds centraux intitulés Law (juridique), Political (politique), Social, Technological (technologique), Economic (économique) et Environment (environnement) sont reliés à de nombreux petits nœuds, chacun correspondant à une tendance formulée comme un titre (par exemple sur COVAX, le nationalisme vaccinal, les pôles de vaccins à ARNm, l’intelligence artificielle et le changement climatique) ; la plupart des petites étiquettes sont trop petites pour être lues avec certitude.",
        "ru": "Сетевая диаграмма узлов, визуализирующая новые тенденции, выявленные в литературе, по схеме PESTLE. Шесть центральных узлов с подписями Law (право), Political (политика), Social (общество), Technological (технологии), Economic (экономика) и Environment (окружающая среда) связаны со множеством мелких узлов, каждый из которых — краткая тенденция в виде заголовка (например, о COVAX, вакцинном национализме, центрах мРНК-вакцин, искусственном интеллекте и изменении климата); большинство мелких подписей слишком малы, чтобы их можно было надежно прочитать."
      },
      "state": "draft"
    },
    {
      "id": "img-p027-1",
      "file": "images/img-p027-1.webp",
      "page": 27,
      "narratives": {
        "en": "A photograph of a meeting room in which participants sit around tables with laptops, papers and refreshments while a man speaks at the head table in front of a projected slide and flags. The caption identifies it as the 2nd consultative workshop, Tabriz, Iran, 27 June 2022.",
        "ar": "صورة لقاعة اجتماعات يجلس فيها المشاركون حول طاولات عليها حواسيب محمولة وأوراق ومرطبات، بينما يتحدث رجل على طاولة الصدارة أمام شريحة معروضة وأعلام. ويوضح التعليق أنها ورشة العمل التشاورية الثانية، تبريز، إيران، 27 يونيو 2022.",
        "zh": "会议室照片，与会者围坐在摆有笔记本电脑、文件和茶点的桌旁，一名男子在主桌前发言，身后是投影幻灯片和旗帜。图注说明这是2022年6月27日在伊朗大不里士举行的第二次磋商研讨会。",
        "es": "Una fotografía de una sala de reuniones en la que los participantes están sentados alrededor de mesas con ordenadores portátiles, papeles y refrigerios, mientras un hombre habla en la mesa principal delante de una diapositiva proyectada y de banderas. El pie de foto la identifica como el 2.º taller consultivo, Tabriz (Irán), 27 de junio de 2022.",
        "fr": "Une photographie d’une salle de réunion où les participants sont assis autour de tables avec des ordinateurs portables, des documents et des rafraîchissements, tandis qu’un homme s’exprime à la table principale devant une diapositive projetée et des drapeaux. La légende l’identifie comme le 2e atelier consultatif, Tabriz (Iran), 27 juin 2022.",
        "ru": "Фотография зала заседаний: участники сидят за столами с ноутбуками, бумагами и угощением, а мужчина выступает за президиумом на фоне проецируемого слайда и флагов. Согласно подписи, это второй консультативный семинар, Тебриз, Иран, 27 июня 2022 года."
      },
      "state": "draft"
    },
    {
      "id": "img-p029-1",
      "file": "images/img-p029-1.webp",
      "page": 29,
      "narratives": {
        "en": "A photograph in a hospital ward: a health worker wearing a face mask holds a folder and talks with a woman seated on a hospital bed, beside whom a young boy is standing. The caption describes surveillance activity at a sentinel site (HNGV) in Timor-Leste.",
        "ar": "صورة في جناح مستشفى: عاملة صحية ترتدي كمامة تحمل ملفًا وتتحدث مع امرأة جالسة على سرير المستشفى، وبجانبها صبي صغير واقف. ويصف التعليق نشاط الترصد في موقع ترصد خافر (HNGV) في تيمور - ليشتي.",
        "zh": "医院病房中的照片：一名戴口罩的卫生工作者手持文件夹，与坐在病床上的一名妇女交谈，旁边站着一个小男孩。图注描述了东帝汶哨点（HNGV）的监测活动。",
        "es": "Una fotografía en una sala de hospital: una trabajadora sanitaria con mascarilla sostiene una carpeta y habla con una mujer sentada en una cama de hospital, junto a la cual está de pie un niño pequeño. El pie de foto describe la actividad de vigilancia en un sitio centinela (HNGV) de Timor-Leste.",
        "fr": "Une photographie dans un service hospitalier : une agente de santé portant un masque tient un dossier et parle avec une femme assise sur un lit d’hôpital, à côté de laquelle se tient un jeune garçon. La légende décrit une activité de surveillance sur un site sentinelle (HNGV) au Timor-Leste.",
        "ru": "Фотография в больничной палате: медицинская работница в маске держит папку и разговаривает с женщиной, сидящей на больничной койке, рядом с которой стоит маленький мальчик. В подписи описывается деятельность по эпиднадзору на дозорном участке (HNGV) в Тиморе-Лешти."
      },
      "state": "draft"
    },
    {
      "id": "img-p029-2",
      "file": "images/img-p029-2.webp",
      "page": 29,
      "narratives": {
        "en": "A photograph of a health worker wearing a face mask and gloves who is placing a sample into a clear plastic specimen bag at a laboratory bench. The caption describes investigating and handling influenza samples at a sentinel site (HNGV) in Timor-Leste before sending them to the National Health Laboratory.",
        "ar": "صورة لعاملة صحية ترتدي كمامة وقفازين وتضع عينة في كيس عينات بلاستيكي شفاف على طاولة مختبر. ويصف التعليق التحقق من عينات الإنفلونزا ومناولتها في موقع ترصد خافر (HNGV) في تيمور - ليشتي قبل إرسالها إلى المختبر الصحي الوطني.",
        "zh": "一名戴口罩和手套的卫生工作者在实验台前将样本放入透明塑料样本袋的照片。图注描述了在东帝汶哨点（HNGV）调查和处理流感样本，并将其送往国家卫生实验室。",
        "es": "Una fotografía de una trabajadora sanitaria con mascarilla y guantes que coloca una muestra en una bolsa de plástico transparente para muestras en una mesa de laboratorio. El pie de foto describe la investigación y manipulación de muestras de gripe en un sitio centinela (HNGV) de Timor-Leste antes de enviarlas al Laboratorio Nacional de Salud.",
        "fr": "Une photographie d’une agente de santé portant un masque et des gants qui place un échantillon dans un sachet plastique transparent pour échantillons sur une paillasse de laboratoire. La légende décrit l’investigation et la manipulation d’échantillons de grippe sur un site sentinelle (HNGV) au Timor-Leste avant leur envoi au Laboratoire national de santé.",
        "ru": "Фотография медицинской работницы в маске и перчатках, которая помещает образец в прозрачный пластиковый пакет для образцов на лабораторном столе. В подписи описываются исследование и обработка образцов на грипп на дозорном участке (HNGV) в Тиморе-Лешти перед их отправкой в Национальную лабораторию здравоохранения."
      },
      "state": "draft"
    },
    {
      "id": "img-p035-1",
      "file": "images/img-p035-1.webp",
      "page": 35,
      "narratives": {
        "en": "A handwritten signature in blue ink, preceded by \"pp.\" (signed on behalf of another person).",
        "ar": "توقيع بخط اليد بالحبر الأزرق، مسبوق بالاختصار \"pp.\" (توقيع بالنيابة عن شخص آخر).",
        "zh": "蓝色墨水的手写签名，带有\"pp.\"字样（代表他人签署）。",
        "es": "Firma manuscrita en tinta azul, precedida de «pp.» (firmado en nombre de otra persona).",
        "fr": "Signature manuscrite à l'encre bleue, précédée de « pp. » (signé par procuration).",
        "ru": "Рукописная подпись синими чернилами с пометкой «pp.» (подписано за другое лицо)."
      },
      "state": "draft"
    },
    {
      "id": "img-p040-1",
      "file": "images/img-p040-1.webp",
      "page": 40,
      "narratives": {
        "en": "A barcode with the ISBN number 9789240076907.",
        "ar": "رمز شريطي برقم ISBN ‏9789240076907.",
        "zh": "带有ISBN号9789240076907的条形码。",
        "es": "Un código de barras con el número ISBN 9789240076907.",
        "fr": "Un code-barres portant le numéro ISBN 9789240076907.",
        "ru": "Штрихкод с номером ISBN 9789240076907."
      },
      "state": "draft"
    }
  ],
  "coverage": [
    {
      "kind": "contents",
      "state": "found",
      "count": 13,
      "note": "outline"
    },
    {
      "kind": "sections",
      "state": "found",
      "count": 14,
      "note": "2 levels"
    },
    {
      "kind": "figures",
      "state": "found",
      "count": 7
    },
    {
      "kind": "tables",
      "state": "not-extracted"
    },
    {
      "kind": "references",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "glossary",
      "state": "none",
      "note": "no such heading in the text"
    },
    {
      "kind": "footnotes",
      "state": "not-extracted"
    },
    {
      "kind": "summaries",
      "state": "found",
      "count": 14,
      "note": "14 of 14 sections"
    }
  ],
  "links": {
    "repo": "WorldHealthOrganization/who-iris",
    "branch": "main",
    "dir": "library/10665-372197"
  }
}
